Renflexis 100 MG vials
Ended Awarded
- Contract number
- SPE2DR26F0FEN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,115
Award facts
- Contract value 100% obligated
- $29,114.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $29,114.73 delivery order to AmerisourceBergen Drug Corp on June 5, 2026, for Renflexis 100 mg vials, with an ultimate completion date of June 8, 2026.
Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside applied. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a pharmaceutical distributor serving federal healthcare systems and the Department of Defense as a prime contractor on the DLA Troop Support Medical indefinite delivery contract portfolio.
Quick answers
Who was awarded contract SPE2DR26F0FEN?
SPE2DR26F0FEN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 5, 2026.
How much is contract SPE2DR26F0FEN worth?
The government has obligated $29,115 on SPE2DR26F0FEN.
Is contract SPE2DR26F0FEN an order under another contract?
Yes. SPE2DR26F0FEN is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F0FEN competed?
The extent of competition for SPE2DR26F0FEN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award